Navigation Links
OCTANe's Medical Device & Investor Forum Highlights Key Trends, Investment Opportunities
Date:11/17/2009

ALISO VIEJO, Calif., Nov. 17 /PRNewswire/ -- OCTANe hosted nearly 700 leading medical device industry executives from over 425 companies to discuss promising technology and emerging trends for the medical device industry last week at the 4th Annual CA Medical Device & Investor Forum.

For the first time on one stage, company leaders from the biggest M&A transactions in Orange County history discussed the details of the deals, and why Orange County is a hotbed for this type of activity. Stephen Oesterle, MD, senior vice president for medicine and technology at Medtronic expressed that large companies like Medtronic will continue to acquire, and that they rely on the innovations of smaller companies and start-ups. Dr. Oesterle was joined by Dan Lamaitre from CoreValve, Jim Mazzo from AMO, Sean Murphy from Abbott and Charles Warden from Versant Ventures.

"This panel of industry stars was an excellent foundation on which the rest of the conference was built," said Matthew Jenusaitis, president and CEO of OCTANe. "The relationship between large companies, emerging growth companies, and the investment world is more important than ever, and this panel reflected OCTANe's mission of stimulating the innovation ecosystem in our region."

More than nine countries and 19 states were represented at the Forum, and on the second day of the conference attendees chose between eight educational panels covering industry insights to cardiovascular, ophthalmology and healthcare IT, device design, IP due diligence, regulatory approvals, and global opportunities. Concurrently, 11 start-ups gave investment presentations, featuring new businesses and technologies in critical areas like orthopedic, breast health, and the neuro interventional market, among others.

The lunch keynote spotlighted Healthcare Policy and Reform, and featured Christopher Cox, former SEC Chairman, as well as other leading DC experts. This discussion was followed by the keynote Investor Panel with Dr. Thomas Fogarty, a cardiovascular surgeon and world-renowned inventor, and leaders from New Leaf, Piper Jaffray, and De Novo Ventures.

Select panel slides, videos, photos and webcasts are available for review at www.octaneforum2009.com.

About OCTANe:

OCTANe is fueling "innovation development" in Orange County and Southern California. By connecting people, capital and technology, OCTANe accelerates entrepreneurs and company development for Orange County's biomedical and technology communities. The organization brings together the region's leading biomedical and information technology companies, promising startups, entrepreneurs, venture capitalists, and universities to help create, grow, support, staff and fund innovative companies. For more information, visit www.octaneoc.org.

    Media Contact: Cynthia Bemis, (949) 330-6566
                   Cynthia.Bemis@octaneoc.org

SOURCE OCTANe


'/>"/>
SOURCE OCTANe
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. China Sky One Medical, Inc. Announces Record Third Quarter 2009 Results
2. Symmetry Medical to Present at 21st Annual Piper Jaffray Health Care Conference
3. Cardo Medical, Inc. Announces Closing of $6.2 Million Private Placement
4. Methodist Dallas Medical Center First in Metroplex to Perform Kidney Transplant on HIV Positive Patient
5. New Database from ANSI, AAMI, ASTM International, and DIN Provides Centralized Source of Information for Medical Device Professionals
6. CardioGenics Holdings Inc. Featured in Medical Device Daily
7. Service Outsourcing Opportunities in Medical Device Market worth US$26.77 Billion by 2014
8. Pulmo BioTech Inc. Announces that Its Pulmonary Vascular Diagnostic Product Candidate PulmoBind(TM) Shows Early Indications of Being Able to Diagnose a Wide Range of Medical Conditions Affecting the Physical and/or Biological Integrity of the Pulmon
9. Cardio Vascular Medical Device Launches Corporate Website
10. Sutter Medical Center Receives Certification to Use Ventricular Assist Devices as Destination Therapy
11. Jefferson Radiology Acquires Two Medical Imaging Center Offices
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... , April 20, 2017 NeuroVive ... ("NeuroVive") today announced positive preclinical results demonstrating ... compound for non-alcoholic steatohepatitis (NASH), in an ... NV556 has previously shown similar ... model. Today, NeuroVive,s scientists present novel data ...
(Date:4/19/2017)... 2017  IRIDEX Corporation (Nasdaq: IRIX ) ... the first quarter 2017 after the close of trading ... will host a corresponding conference call beginning at 2:30 ... interested in listening to the conference call may do ... (703) 326-3030 for international callers, using conference ID: 92158987.  ...
(Date:4/19/2017)... 2017  Sorrento Therapeutics, Inc. (NASDAQ: ... developing new treatments for cancer and other unmet ... previously announced underwritten public offering of 23,625,084 shares ... price of $2.00 per share, before deducting underwriting ... by Sorrento.  The net proceeds to Sorrento from ...
Breaking Medicine Technology:
(Date:4/25/2017)... , ... April 25, 2017 , ... Back Pain ... and back pain with a reputable physician in their area, announces the launch of ... patient information for patients who are looking for reputable physicians to help them with ...
(Date:4/25/2017)... ... April 25, 2017 , ... Saad B. Chaudhary, MD is committed to providing the highest ... chronic problems, I focus on preventative care with all my patients to alleviate possible future ... always feel free to contact my office and my trained staff will assist you in ...
(Date:4/25/2017)... ... , ... Emergency Physician and Distinguished Professor of Emergency Medicine Bentley Bobrow will ... set to publish in summer 2017. , Dr. Bobrow, MD, FACEP, FAHA, is ... of Medicine. He also serves as Medical Director for the Bureau of Emergency Medical ...
(Date:4/25/2017)... ... , ... Vetoquinol USA® , a world-class developer of ... the EQUISTRO line, at this week’s Rolex Kentucky Three-Day Event in Lexington. Flexadin ... , The scientifically-developed Flexadin UCII supports the body’s normal repair of cartilage and ...
(Date:4/24/2017)... ... April 24, 2017 , ... Emmanuel College is introducing ... advance their careers. Beginning in the fall of 2017, Emmanuel’s program will allow registered ... few as 16 months and for as little as $14,528. These changes will enable ...
Breaking Medicine News(10 mins):